These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 12932169)

  • 1. Leucine 7 to proline 7 polymorphism of the preproneuropeptide Y gene is not associated with restenosis after coronary stenting.
    Pesonen U; Koch W; Schömig A; Kastrati A
    J Endovasc Ther; 2003 Jun; 10(3):566-72. PubMed ID: 12932169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.
    Erkkilä AT; Lindi V; Lehto S; Laakso M; Uusitupa MI
    Mol Genet Metab; 2002 Mar; 75(3):260-4. PubMed ID: 11914038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y signal peptide Pro7 substitution protects against coronary artery atherosclerosis: the Helsinki Sudden Death Study.
    Ilveskoski E; Viiri LE; Mikkelsson J; Pörsti I; Lehtimäki T; Karhunen PJ
    Atherosclerosis; 2008 Aug; 199(2):445-50. PubMed ID: 18054939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene and changes in serum lipids during a family-based counselling intervention among school-aged children with a family history of CVD.
    Salminen M; Lehtimäki T; Fan YM; Vahlberg T; Kivelä SL
    Public Health Nutr; 2008 Nov; 11(11):1156-62. PubMed ID: 18279562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leucine7 to proline7 polymorphism in prepro-NPY gene and femoral neck bone mineral density in postmenopausal women.
    Heikkinen AM; Niskanen LK; Salmi JA; Koulu M; Pesonen U; Uusitupa MI; Komulainen MH; Tuppurainen MT; Kröger H; Jurvelin J; Saarikoski S
    Bone; 2004 Sep; 35(3):589-94. PubMed ID: 15336593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leu7Pro polymorphism of PreproNPY associated with an increased risk for type II diabetes in middle-aged subjects.
    Ukkola O; Kesäniemi YA
    Eur J Clin Nutr; 2007 Sep; 61(9):1102-5. PubMed ID: 17268419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leucine7 to proline7 polymorphism in the preproneuropeptide Y is associated with the progression of carotid atherosclerosis, blood pressure and serum lipids in Finnish men.
    Karvonen MK; Valkonen VP; Lakka TA; Salonen R; Koulu M; Pesonen U; Tuomainen TP; Kauhanen J; Nyyssönen K; Lakka HM; Uusitupa MI; Salonen JT
    Atherosclerosis; 2001 Nov; 159(1):145-51. PubMed ID: 11689216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with proteinuria, coronary heart disease, and glycemic control in type 1 diabetic patients.
    Pettersson-Fernholm K; Karvonen MK; Kallio J; Forsblom CM; Koulu M; Pesonen U; Fagerudd JA; Groop PH;
    Diabetes Care; 2004 Feb; 27(2):503-9. PubMed ID: 14747236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leucine 7 to proline 7 polymorphism in the preproneuropeptide Y is associated with birth weight and serum triglyceride concentration in preschool aged children.
    Karvonen MK; Koulu M; Pesonen U; Uusitupa MI; Tammi A; Viikari J; Simell O; Rönnemaa T
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1455-60. PubMed ID: 10770181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting.
    Böttiger C; Koch W; Lahn C; Mehilli J; von Beckerath N; Schömig A; Kastrati A
    Am Heart J; 2003 Nov; 146(5):855-61. PubMed ID: 14597935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low prevalence of the Leu7/Pro polymorphism in the signal peptide of preproneuropeptide Y in the Spanish Mediterranean population].
    Portolés O; Sorlí JV; González JI; Ruiz de la Fuente S; Ramírez JB; Corella D
    Med Clin (Barc); 2003 Mar; 120(9):337-9. PubMed ID: 12646110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Leu7Pro polymorphism of preproNPY is associated with decreased insulin secretion, delayed ghrelin suppression, and increased cardiovascular responsiveness to norepinephrine during oral glucose tolerance test.
    Jaakkola U; Kuusela T; Jartti T; Pesonen U; Koulu M; Vahlberg T; Kallio J
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3646-52. PubMed ID: 15797951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PreproNPY Pro7 protects against depression despite exposure to environmental risk factors.
    Sjöholm LK; Melas PA; Forsell Y; Lavebratt C
    J Affect Disord; 2009 Nov; 118(1-3):124-30. PubMed ID: 19264362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced endothelium-dependent vasodilation in subjects with Proline7 substitution in the signal peptide of neuropeptide Y.
    Järvisalo MJ; Jartti L; Karvonen MK; Pesonen U; Koulu M; Marniemi J; Hammar N; Kaprio J; Paakkunainen U; Simell O; Raitakari OT; Rönnemaa T
    Atherosclerosis; 2003 Apr; 167(2):319-26. PubMed ID: 12818415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine 7 to proline 7 polymorphism in the neuropeptide y gene is associated with retinopathy in type 2 diabetes.
    Niskanen L; Voutilainen-Kaunisto R; Teräsvirta M; Karvonen MK; Valve R; Pesonen U; Laakso M; Uusitupa MI; Koulu M
    Exp Clin Endocrinol Diabetes; 2000; 108(3):235-6. PubMed ID: 10926322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microsatellite polymorphism of heme oxygenase-1 is associated with baseline plasma IL-6 level but not with restenosis after coronary in-stenting.
    Li P; Elrayess MA; Gomma AH; Palmen J; Hawe E; Fox KM; Humphries SE
    Chin Med J (Engl); 2005 Sep; 118(18):1525-32. PubMed ID: 16232329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear receptors gene polymorphisms and risk of restenosis and clinical events following coronary stenting.
    Neugebauer P; Goldbergová-Pávková M; Kala P; Bocek O; Jerábek P; Poloczek M; Vytiska M; Parenica J; Mikulík R; Jarkovský J; Semrád B; Spinar J; Vasků A
    Vnitr Lek; 2009 Dec; 55(12):1135-40. PubMed ID: 20070029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of a CD18 gene polymorphism with a reduced risk of restenosis after coronary stenting.
    Koch W; Böttiger C; Mehilli J; von Beckerath N; Neumann FJ; Schömig A; Kastrati A
    Am J Cardiol; 2001 Nov; 88(10):1120-4. PubMed ID: 11703955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 5A/6A polymorphism of the stromelysin-1 gene and restenosis after percutaneous coronary interventions.
    Hoppmann P; Koch W; Schömig A; Kastrati A
    Eur Heart J; 2004 Feb; 25(4):335-41. PubMed ID: 14984923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of RAGE gene polymorphisms with in-stent restenosis in non-diabetic Korean population.
    Shim CY; Park S; Yoon SJ; Park HY; Kim HT; Oh B; Park C; Ko YG; Choi D; Jang Y; Chung N
    Cardiology; 2007; 107(4):261-8. PubMed ID: 16954682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.